Novo CEO pressed by Senate to cut selling prices of weight problems, diabetes medicine CEO Lars Fruergaard Jørgensen told lawmakers the corporation would take into consideration new talks with insurers with regard to the listing charges of Wegovy and copyright whenever they pledge to help keep the medicines on their https://kethek.com/